相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Strain-specific antiviral activity of iminosugars against human influenza A viruses
S. Hussain et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
In Vivo Therapeutic Protection against Influenza A (H1N1) Oseltamivir-Sensitive and Resistant Viruses by the Iminosugar UV-4
Eric J. Stavale et al.
PLOS ONE (2015)
Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
Jenny G. Low et al.
LANCET INFECTIOUS DISEASES (2014)
Glycosylation, Hypogammaglobulinemia, and Resistance to Viral Infections
Mohammed A. Sadat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Emerging Principles for the Therapeutic Exploitation of Glycosylation
Martin Dalziel et al.
SCIENCE (2014)
An iminosugar with potent inhibition of dengue virus infection in vivo
Stuart T. Perry et al.
ANTIVIRAL RESEARCH (2013)
Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2013)
Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2013)
Glycoprotein misfolding in the endoplasmic reticulum: identification of released oligosaccharides reveals a second ER-associated degradation pathway for Golgi-retrieved proteins
Dominic S. Alonzi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial
Satoru Watanabe et al.
ANTIVIRAL RESEARCH (2012)
Restricted processing of glycans by endomannosidase in mammalian cells
Nikolay V. Kukushkin et al.
GLYCOBIOLOGY (2012)
Competitive inhibitor of cellular α-glucosidases protects mice from lethal dengue virus infection
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2011)
Combination of alpha-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2011)
Therapeutic Strategies for Gaucher Disease: Miglustat (NB-DNJ) as a Pharmacological Chaperone for Glucocerebrosidase and the Different Thermostability of Velaglucerase Alfa and Imiglucerase
Olga Abian et al.
MOLECULAR PHARMACEUTICS (2011)
STAT2 Mediates Innate Immunity to Dengue Virus in the Absence of STAT1 via the Type I Interferon Receptor
Stuart T. Perry et al.
PLOS PATHOGENS (2011)
Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease
Raphael M. Zellweger et al.
CELL HOST & MICROBE (2010)
Cardif-Mediated Signaling Controls the Initial Innate Response to Dengue Virus In Vivo
Stuart T. Perry et al.
JOURNAL OF VIROLOGY (2009)
N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery
Stephanie Pollock et al.
AIDS (2008)
Glucosylated free oligosaccharides are biomarkers of endoplasmicreticulum α-glucosidase inhibition
Dominic S. Alonzi et al.
BIOCHEMICAL JOURNAL (2008)
A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads
Tyler R. Prestwood et al.
JOURNAL OF VIROLOGY (2008)
CLEC5A is critical for dengue-virus-induced lethal disease
Szu-Ting Chen et al.
NATURE (2008)
Antiviral effects of an iminosugar derivative on flavivirus infections
SF Wu et al.
JOURNAL OF VIROLOGY (2002)
Effect of glycosylation and glucose trimming inhibitors on the influenza A virus glycoproteins
T Saito et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2000)
分享论文
